Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€125.18
28.05.21
€200.00
28.05.22
-35.69%
29.01.22

Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies
buy
iBio Inc.

Start price
Target price
Perf. (%)
€30.56
28.05.21
€25.00
28.05.22
-45.75%
01.11.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€9.52
27.05.21
€32.00
27.05.22
-55.61%
28.05.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€75.60
26.05.21
€82.00
26.05.22
-36.11%
27.05.22

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€19.02
19.05.21
-
19.05.22
25.45%
22.06.21

Risky Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.10
19.05.21
€80.00
19.11.21
-1.41%
26.05.21

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€3.92
17.05.21
€5.00
17.05.22
6.12%
31.05.21

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.65
17.05.21
€8.00
17.05.22
1.50%
31.05.21

Could be worthwhile Investment >10% per year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€4.44
17.05.21
€6.00
17.05.22
2.70%
31.05.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€6.73
17.05.21
€8.00
17.05.22
7.58%
31.05.21

Could be very worthwhile Investment >20% year
buy
Calithera Biosciences Inc.

Start price
Target price
Perf. (%)
€35.80
17.05.21
-
17.05.22
-88.46%
18.05.22

Could be worthwhile Investment >10% per year
buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€26.00
16.05.21
€40.00
16.05.22
-5.77%
29.01.22

Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€15.25
06.05.21
€18.40
06.05.22
23.09%
11.06.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
iBio Inc.

Start price
Target price
Perf. (%)
€33.50
06.05.21
€25.00
06.05.22
-8.77%
28.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€40.55
04.05.21
€55.00
04.05.22
-11.84%
05.05.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€27.36
04.05.21
€12.00
04.05.22
-39.47%
05.05.21

Could be worthwhile Investment >10% per year
Good culture
Little innovation
buy
Immutep LTD ADR

Start price
Target price
Perf. (%)
€2.70
04.05.21
-
04.05.22
-8.89%
05.05.22

Could be very worthwhile Investment >20% year
buy
Precipio Inc

Start price
Target price
Perf. (%)
€5.51
04.05.21
-
04.05.22
-82.03%
05.05.22

Could be very worthwhile Investment >20% year
buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€71.50
03.05.21
€78.00
03.05.22
2.80%
04.05.22

Could be worthwhile Investment >10% per year
buy
Precipio Inc

Start price
Target price
Perf. (%)
€2.03
03.05.21
€3.00
03.05.22
194.54%
04.05.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
Few uniques
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-41.82%
04.05.22

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.50
03.05.21
€8.00
03.05.22
2.31%
17.05.21

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.72
03.05.21
€5.00
03.05.22
-5.88%
17.05.21

Could be worthwhile Investment >10% per year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€4.72
03.05.21
€6.00
03.05.22
-5.93%
17.05.21

Could be worthwhile Investment >10% per year